Navigation Links
CRH Medical Corporation opens Center in New York
Date:5/15/2008

VANCOUVER, May 15 /PRNewswire-FirstCall/ - CRH Medical Corporation (CRM:TSX-V) announced today that it has opened a Center for Colorectal Health in Bay Shore, Long Island. This Center is the Company's first in the state of New York, one of many new markets that CRH has targeted for expansion. The opening of this location represents the 6th new Center opened in 2008 bringing the Company's total number of Centers to 14.

According to the National Institute of Health, the prevalence rate of hemorrhoids in the US is about 4.4% of the population. Approximately 50% of the U.S. population will develop hemorrhoids by age 50. The Company plans to significantly increase the number of Centers for Colorectal Health across the U.S. to address this underserved market.

About CRH Medical Corporation:

CRH Medical Corporation specializes in the treatment of hemorrhoids utilizing its proven treatment protocol and patented proprietary technology. CRH's single use, disposable, hemorrhoid technology is safe and highly effective in treating hemorrhoid grades I - IV. CRH Medical employs two commercialization strategies: First, it operates Centers for Colorectal Health facilities in the United States specializing in the treatment of hemorrhoids and fissures, and colon cancer screening. In addition CRH distributes its hemorrhoid banding technology, treatment protocols, operational and marketing expertise as a complete, "turn key" package directly to its partner physicians. The Company's goal is to establish the CRH hemorrhoid technology as the standard for hemorrhoid treatment.

The information in this news release contains so-called "forward-looking" statements. These include statements regarding CRH Medical expectations, beliefs, intentions or strategies for the future, which may be indicated by words or phrases such as "anticipate", "expect", "intend", "plan", "will", "we believe", "CRH Medical believes", "management believes" and similar language. All forward-looking statements are based on CRH Medical current expectations and are subject to risks and uncertainties and to assumptions made.

The TSX Venture Exchange does not accept responsibility for the adequacy

or accuracy of this release.

CONTACT: Dean Linden, Investor Relations, CRH Medical Corporation at (604) 633-1440 or ir@crhmedcorp.com; Additional information may also be found by visiting the Company's website at http://www.crhmedcorp.com or the SEDAR website at http://www.sedar.com


'/>"/>
SOURCE CRH Medical Corporation
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Mindray Medical Completes Acquisition of Datascopes Patient Monitoring Business
2. RNC RESPONSE TO OBAMA COMMENTS ON MEDICAL MARIJUANA LAWS
3. LMS Medical Sees Fiscal 2008 Revenue Jump 72% Over F07 - Q4/F08 Revenue Hits New Record
4. UNICEF Rushing Medical Supplies, Tents, Clean Water to Children Affected by Powerful Earthquake in China
5. Milliman Says 2008 Medical Cost for American Family of Four Exceeds $15,600
6. Study Suggests Green Tea May Support the Medical Treatment of Stomach and Colon Cancer
7. Rising Medical Solutions and CEO Are Featured as a Case Study in the Effective Small Business Management, Ninth Edition Textbook
8. Blue Cross and Blue Shield of Illinois Names New Chief Medical Officer
9. China Sky One Medical, Inc. to Present at Brean Murray Carret & Co. All-Cap All-China Conference
10. China Sky One Medical, Inc. Announces Conference Call to Discuss First Quarter 2008 Results
11. Visage Imaging to Provide Fully Integrated Thin Client-Based Solution to Tufts Medical Center
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/26/2017)... ... April 26, 2017 , ... RawTrition now brings you BioEnergy which ... nutrients from SUPERFOODS! , RawTrition is taking nutrients to the next level! ... the body recognizes its raw form (unlike the synthetically made options that are on ...
(Date:4/26/2017)... ... April 26, 2017 , ... MYOLYN, a medical technology company ... has received 510(k) clearance from the U.S. Food & Drug Administration (FDA) for ... Both devices are stationary cycling systems that use MYOLYN’s patent-pending functional electrical ...
(Date:4/25/2017)... ... April 25, 2017 , ... ... committed to raising awareness for Duchenne muscular dystrophy, and funding for Duchenne ... (cardiosphere-derived cells) Phase I/II HOPE clinical trial in Duchenne announced today. , ...
(Date:4/25/2017)... ... April 25, 2017 , ... The doctors at Wall Centre Dental ... with dental fear and require sedation to receive dental care. The doctors offer three ... procedures, from hygienic cleanings to oral surgery, at their dental office in Vancouver. Wall ...
(Date:4/25/2017)... ... April 25, 2017 , ... ... in unveiling cutting-edge birth defects research related to Zika virus during pregnancy, as ... premier society for this important science. , The Teratology Society ...
Breaking Medicine News(10 mins):
(Date:4/19/2017)... 2017  Novartis today announced the publication of ... and Blood Institute (NHLBI) of the National Institutes ... with treatment-naïve severe aplastic anemia (SAA) achieved complete ... at the initiation of and concurrently with standard ... sequential treatment groups, or cohorts. Cohort 3 added ...
(Date:4/18/2017)... DUBLIN, Ohio , April 18, 2017  Cardinal ... its Non-GAAP 1 fiscal 2017 earnings per share ... 2018 and 2019.  This is in conjunction with this ... Care, Deep Vein Thrombosis and Nutritional Insufficiency businesses. ... EPS from continuing operations will be at the bottom ...
(Date:4/18/2017)... Viverae ® , a leader in workplace wellness technology, ... Watson Campaign Automation, implementing behavioral messaging within the ... experience. Through digital engagement, the platform prompts members to ... The enhanced experience drives engagement by focusing on the ... in their journey to health. Unlike ...
Breaking Medicine Technology: